TFF Pharmaceuticals, Inc.
DelistedCIK 1733413fmd_1JZ4ZW8YDHC1QS8M4ARTDK66EXManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Sep 30, 2024, 25 periods
Latest annual · FY2023
Millions- Total revenues
- 1
- Operating income
- (22)
- Net income
- (21)
- Free cash flow
- (16)
Latest quarter · Q3 FY2024
Millions- Total revenues
- 0
- Operating income
- (4)
- Net income
- (4)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- n/m
TFF Pharmaceuticals, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $733,871 | $495,805 | +48% | 10-K 2024-03-28 · proof |
| Operating income | -$21.9 million | -$31.8 million | 10-K 2024-03-28 · proof | |
| Net income | -$21.2 million | -$31.8 million | 10-K 2024-03-28 · proof | |
| Cash from operating activities | -$16 million | -$27.3 million | 10-K 2024-03-28 · proof | |
| Free cash flow | -$16.1 million | -$28.9 million | 10-K 2024-03-28 · proof | |
| Total assets | $12 million | $24.1 million | -50.1% | 10-K 2024-03-28 · proof |
| Total liabilities | $2.5 million | $1.2 million | +98.3% | 10-K 2024-03-28 · proof |
| Cash and cash equivalents | $5.5 million | $16.6 million | -67% | 10-K 2024-03-28 · proof |
- What was TFF Pharmaceuticals, Inc.'s revenue in fiscal 2023?
- TFF Pharmaceuticals, Inc. reported revenue of $733,871 for fiscal 2023 (the year ended Dec 31, 2023), against $495,805 the year before (+48%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What was TFF Pharmaceuticals, Inc.'s operating income in fiscal 2023?
- TFF Pharmaceuticals, Inc. reported operating income of -$21.9 million for fiscal 2023 (the year ended Dec 31, 2023), against -$31.8 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What was TFF Pharmaceuticals, Inc.'s net income in fiscal 2023?
- TFF Pharmaceuticals, Inc. reported net income of -$21.2 million for fiscal 2023 (the year ended Dec 31, 2023), against -$31.8 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What was TFF Pharmaceuticals, Inc.'s cash from operating activities in fiscal 2023?
- TFF Pharmaceuticals, Inc. reported cash from operating activities of -$16 million for fiscal 2023 (the year ended Dec 31, 2023), against -$27.3 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What was TFF Pharmaceuticals, Inc.'s free cash flow in fiscal 2023?
- TFF Pharmaceuticals, Inc. reported free cash flow of -$16.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$28.9 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What are TFF Pharmaceuticals, Inc.'s total assets?
- As of Dec 31, 2023, TFF Pharmaceuticals, Inc. reported total assets of $12 million, against $24.1 million a year earlier (-50.1%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What are TFF Pharmaceuticals, Inc.'s total liabilities?
- As of Dec 31, 2023, TFF Pharmaceuticals, Inc. reported total liabilities of $2.5 million, against $1.2 million a year earlier (+98.3%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What are TFF Pharmaceuticals, Inc.'s cash and cash equivalents?
- As of Dec 31, 2023, TFF Pharmaceuticals, Inc. reported cash and cash equivalents of $5.5 million, against $16.6 million a year earlier (-67%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1733413&period_type=annual&limit=5"Information only, not investment advice.